The Securities and Exchange Commission approved registration statements for Lycia Therapeutics, Inc. on October 1, 2026.
1 report, 1 independent
Updated Oct 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The Securities and Exchange Commission approved registration statements for Lycia Therapeutics, Inc. on October 1, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- 60 Degrees Pharmaceuticals, Inc. filed a registration statement with the Securities and Exchange Commission on July 17, 2025.
- BioTech filed a registration statement with the Securities and Exchange Commission on October 7, 2026.
- Medpace filed required documents with the Securities and Exchange Commission on August 15, 2026.
- Quince Therapeutics plans to file its financial results with the Securities and Exchange Commission.